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Histologic grading: A, B, C or 1, 2, 3?
To the Editor:
Mr Lee and colleagues from Dr Shennib's group are to be
congratulated for an interesting and provocative study (J
Thorac Cardiovasc Surg 1998;115:822-7) that supports their
hypothesis that bronchiolitis obliterans is not related just to
chronic rejection in lung allografts. Using activated charcoal
as an airway irritant, the authors demonstrated that either an
irritant alone or reduced immunosuppression after transplan-
tation resulted in mild bronchiolitis, but the combination of
airway irritant and reduced immunosuppression produced
more impressive histologic findings consistent with oblitera-
tive bronchiolitis.
However, I take issue with the calculation of mean grades
of airway injury using a grading system that arbitrarily
assigns numbers to histologic patterns of injury. If the histo-
logic categories were labeled A, B, C, and D instead of 1, 2,
3, and 4, what would be the mean of 2 A's and 3 C's? It would
be statistically appropriate to compare the groups by looking
at the distribution of scores within each group, rather than
calculating a mean from data that are not arithmetic.
Although this is common practice with histologic grades, it is
mathematically inappropriate. Unfortunately, the need for
nonparametric analysis translates into a requirement for a
much larger number of animals to establish statistical signif-
icance to the observation. This criticism is not meant to
detract from the elegance of the experiment but only to raise
the point that not all observations need to be "statistically sig-
nificant" before they are relevant. Perhaps the authors could
share the distribution of scores, rather than the mean scores.
Thomas M. Egan, MD
Professor
Associate Division Chieffor General Thoracic Surgery
Department ofSurgery
University ofNorth Carolina at Chapel Hill
108 Burnett-Womack Building
CB 7065
Chapel Hill, NC 27599-7065
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Reply to the Editor:
The comment made by Dr Thomas Egan is well taken.
Grading the severity of airway injury by nonparametric
analysis requires an extensive number of animals, which we
could not determine before the experiment. When data were
reviewed by classification A, B, C, and D instead of 1, 2, 3,
and 4, we found there were 5 A's and 3 B's in group I (trans-
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plantation alone), 4 C's and 6 D's in group II (transplantation
plus charcoal), and 2 A's, 7 B's, and 1 C in group III (char-
coal alone). As such, the data stand to confirm that the com-
bination of transplantation and charcoal transtracheal injec-
tion result in more pronounced injury to the airway.
Hani Shennib, MD
Associate Professor
Department of Cardiothoracic Surgery
Adel Giaid, MD
Associate Professor
Department ofPathology
McGill University
Montreal, Quebec, Canada
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Multiple primary lung carcinomas
To the Editor:
The report by Okada and colleagues! highlights the treat-
ment options and survival statistics that are appropriate for
patients with multiple primary lung carcinomas (MPLCs),
but we think some further points need to be discussed.
In a recent article by Antakli and colleagues,2 a set of cri-
teria modified from Martini and Melamed3 has been applied
to differentiate MPLCs and recurrence of satellite nodules. In
addition to those mentioned by Okada and associates, associ-
ated premalignant lesions and different DNA ploidy have
been presented as the 2 other criteria in the case of identical
histologic type.2 When Martini and Melamed's criteria were
not conclusive, they advocated DNA ploidy to provide a def-
inite answer to this dilemma. However, Okada and colleagues
have not suggested using the ploidy issue for patients with
MPLCs.
We performed left pneumonectomy for a 60-year-old man
who was operated on for squamous cell carcinoma of the lung
(T2 Nl MO, grade III). One year after the operation, a nodule
with a 2.5-cm diameter located in the right upper lobe was
detected by both chest roentgenography and chest computed
tomography. Segmentectomy was performed, and the histo-
logic type of this tumor was the same as that of the first one
(T2 NO MO, grade III). We considered this tumor to be a sec-
ond primary lung cancer, because the tumor was anatomical-
ly separate and did not have any systemic metastases or medi-
astinal spread. On the other hand, although the number of
criteria that had to be met in the case of identical histologic
type was sufficient, we used the ploidy issue in our patient.
Even though the histologic features were the same in all of
the lesions, the DNA ploidy signatures differed.
Although lung-saving procedures for a primary lesion are
advocated in the article, 1 the risk of having MPLCs after
pneumonectomy is significantly lower than after lobectomies
or miniresections.2
Another point is the striking prevalence of smoking among
the patients with MPLCs and the preventive effect of cessa-
tion that has been demonstrated by many authors.2,4 Do
Okada and associates have any information about the preva-
lence of smoking among their patients?
From the historical point of view, we would like to know
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whether the first case of MPLCs was described by Beyreuther
in 1924, as mentioned by Okada and colleagues,1 or whether
the first case was described in 1928, as pointed out by
Chaudhuri.5
Bedrettin Ylldlzeli, MD
Mustafa Yiiksel, MD
Sina Ercan, MD
Hasan F. Batlrel, MD
Marmara University Faculty ofMedicine
Department ofThoracic Surgery
Istanbul, Turkey
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Reply to the Editor:
It is our pleasure to address the points raised by Ytldtzeli
and associates in their letter regarding our recently published
article. l We had already assessed the characteristics of small
non-small cell lung cancers with DNA ploidy. This study con-
sisted of 39% aneuploidy and 61 % diploidy tumors and sug-
gested that DNA ploidy was a prognostic factor and that ane-
uploidy possessed occult malignancy.2 However, we do not
think that the DNA ploidy is the definitive answer to the
dilemma whether a tumor is a second primary or a recurrence.
When the 2 tumors had completely different patterns of DNA
ploidy, they were defined as second primaries. However, as
shown in many previous reports,3-5 all specimens had normal
(diploid) peaks, which were made by tumor cells and normal
epithelial or stromal cells (or both) within tumors. Even with
cytofluorometric evaluation of lung cancer, which can theo-
retically select only tumor cells, most tumors contained nor-
mal peaks.6 Therefore we have speculated on the sensitivity
and specificity of the ploidy results regarding the differentia-
tion between second primaries and metastases. We have fol-
lowed the policy that lung-saving procedures such as bron-
choplasty for a primary lesion must always be kept in mind.
Of 671 patients who underwent operations for primary lung
cancer over a period of 6 years, we considered 39 patients to
have pT2 Nl MO disease. None was subjected to pneu-
monectomy, and 14 (36%) underwent sleeve lobectomy
instead. We succeeded in preserving lung function with a rea-
sonable prognosis and a better postoperative quality of life,
which was proven by spirometry and treadmill exercise
test.7,8 Needless to say, pneumonectomy decreases the chance
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of a second primary significantly compared with lobectomy,
because removal of more lung tissue with the first tumor
would leave the patient with less lung tissue in which a sec-
ond primary could develop later, Preservation of lung func-
tion, however, is much more important than the risk of second
primary lesions.
A smoking index (cigarettes/day x years) of more than 600
at the time of diagnosis of the second tumor was recorded in
43 patients (75%), suggesting a remarkable incidence of
smoking among patients with multiple primary tumors. This
probably accounts for the high proportion of squamous cell
carcinomas in our series.
Chaudhuri,9 like us, 1 mentioned that Beyreuther described
the first case of multiple primary lung cancer in 1924.
Morihito Okada, MD
Noriaki Tsubota, MD
Department ofThoracic Surgery
Hyogo Medical Center for Adults
Kitaohji-cho 13-70, Akashi City
Hyogo, 673 Japan
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Profound systemic hypothermia and release of
neurotransmitter amino acids
To the Editor:
We read with great interest the article titled "Profound
Systemic Hypothermia Inhibits the Release of Neuro-
transmitter Amino Acids in Spinal Cord Ischemia" by Rokkas
and associates (J Thorac Cardiovasc Surg 1995;110:27-35).
Although considerable information is provided, we believe it
needs to be placed in the proper perspective to lead to a cor-
